These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 31007133)
1. Identification of the Identical Human Mutation in Casal ML; Engiles JB; Zakošek Pipan M; Berkowitz A; Porat-Mosenco Y; Mai W; Wurzburg K; Xu MQ; Allen R; ODonnell PA; Henthorn PS; Thompson K; Shore EM Vet Pathol; 2019 Jul; 56(4):614-618. PubMed ID: 31007133 [TBL] [Abstract][Full Text] [Related]
2. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva. Towler OW; Shore EM; Kaplan FS Bone; 2020 Jan; 130():115116. PubMed ID: 31655222 [TBL] [Abstract][Full Text] [Related]
3. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation. Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819 [TBL] [Abstract][Full Text] [Related]
4. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling. Barruet E; Morales BM; Lwin W; White MP; Theodoris CV; Kim H; Urrutia A; Wong SA; Srivastava D; Hsiao EC Stem Cell Res Ther; 2016 Aug; 7(1):115. PubMed ID: 27530160 [TBL] [Abstract][Full Text] [Related]
5. Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva. Chakkalakal SA; Shore EM Methods Mol Biol; 2019; 1891():247-255. PubMed ID: 30414138 [TBL] [Abstract][Full Text] [Related]
6. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Kaplan FS; Xu M; Seemann P; Connor JM; Glaser DL; Carroll L; Delai P; Fastnacht-Urban E; Forman SJ; Gillessen-Kaesbach G; Hoover-Fong J; Köster B; Pauli RM; Reardon W; Zaidi SA; Zasloff M; Morhart R; Mundlos S; Groppe J; Shore EM Hum Mutat; 2009 Mar; 30(3):379-90. PubMed ID: 19085907 [TBL] [Abstract][Full Text] [Related]
7. Imaging diagnosis: fibrodysplasia ossificans progressiva in a cat. Klang A; Kneissl S; Glänzel R; Fuchs-Baumgartinger A Vet Radiol Ultrasound; 2013; 54(5):532-5. PubMed ID: 23578335 [TBL] [Abstract][Full Text] [Related]
8. Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1. Whyte MP; Wenkert D; Demertzis JL; DiCarlo EF; Westenberg E; Mumm S J Bone Miner Res; 2012 Mar; 27(3):729-37. PubMed ID: 22131272 [TBL] [Abstract][Full Text] [Related]
9. ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report. Nakahara Y; Katagiri T; Ogata N; Haga N Am J Med Genet A; 2014 Jan; 164A(1):220-4. PubMed ID: 24259422 [TBL] [Abstract][Full Text] [Related]
10. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1 Convente MR; Chakkalakal SA; Yang E; Caron RJ; Zhang D; Kambayashi T; Kaplan FS; Shore EM J Bone Miner Res; 2018 Feb; 33(2):269-282. PubMed ID: 28986986 [TBL] [Abstract][Full Text] [Related]
11. Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva. Ratbi I; Bocciardi R; Regragui A; Ravazzolo R; Sefiani A Clin Rheumatol; 2010 Jan; 29(1):119-21. PubMed ID: 19795179 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice. Lounev V; Groppe JC; Brewer N; Wentworth KL; Smith V; Xu M; Schomburg L; Bhargava P; Al Mukaddam M; Hsiao EC; Shore EM; Pignolo RJ; Kaplan FS J Bone Miner Res; 2024 May; 39(4):382-398. PubMed ID: 38477818 [TBL] [Abstract][Full Text] [Related]
13. BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP). Towler OW; Shore EM Dev Dyn; 2022 Jan; 251(1):164-177. PubMed ID: 34133058 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification. Yamamoto M; Stoessel SJ; Yamamoto S; Goldhamer DJ J Bone Miner Res; 2022 Nov; 37(11):2077-2093. PubMed ID: 35637634 [TBL] [Abstract][Full Text] [Related]
15. Difficult diagnosis and genetic analysis of fibrodysplasia ossificans progressiva: a case report. Tian S; Zhu J; Lu Y BMC Med Genet; 2018 Feb; 19(1):30. PubMed ID: 29482508 [TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular characterisation of two siblings with fibrodysplasia ossificans progressiva, from the Colombian Pacific coast (South America). Pachajoa H; Botero AF BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26055602 [TBL] [Abstract][Full Text] [Related]
17. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva. Alessi Wolken DM; Idone V; Hatsell SJ; Yu PB; Economides AN Bone; 2018 Apr; 109():210-217. PubMed ID: 28629737 [TBL] [Abstract][Full Text] [Related]
18. A fibrodysplasia ossificans progressiva patient with a rare missense mutation in ACVR1 detected on Ni H; Tang S; Zhang Y Joint Bone Spine; 2024 Mar; 91(2):105682. PubMed ID: 38159793 [TBL] [Abstract][Full Text] [Related]